400-82-02
8.6
[]. Christopher C Blyth, et al. Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. J Paediatr Child Health. 202 Sep;48(9):846-.
[2]. Julia Dinger, et al. Development of an in vitro cytochrome P40 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse. Toxicol Lett. 204 Oct ;230():28-3.
[3]. Nicola Austin, et al. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. Cochrane Database Syst Rev. 203 Mar 28:(3):CD00348.
[4]. Nripendra Nath Mishra, et al. Arachidonic acid affects biofilm formation and PGE2 level in Candida albicans and non-albicans species in presence of subinhibitory concentration of fluconazole and terbinafine. Braz J Infect Dis. 204 May-Jun;8(3):28-93.
[]. Raimunda Samia Nogueira Brilhante, et al. Antifungal susceptibility and virulence attributes of animal-derived isolates of Candida parapsilosis complex. J Med Microbiol. 204 Nov;63(Pt ):68-2.
H302-H360-H42
P264-P20-P23-P280-P330-P40-P0
GHS0,GHS08
04069 现货
￥ ñǬIJėė -g
293 货期咨询
￥ ñǬėėIJėė -mg
3094 货期咨询
9849 货期咨询
3094 货期咨询
3096 货期咨询
30924 货期咨询
3089 货期咨询
20466 货期咨询
￥ ŕǛŨǬIJėė -g
30933 货期咨询
￥ ŕŇñIJėė -0mg
沪ICP备0964号
